rs75382114

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_022489.4(INF2):​c.3069C>T​(p.Pro1023Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00606 in 1,563,498 control chromosomes in the GnomAD database, including 53 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0047 ( 3 hom., cov: 34)
Exomes 𝑓: 0.0062 ( 50 hom. )

Consequence

INF2
NM_022489.4 synonymous

Scores

3

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: -0.766

Publications

0 publications found
Variant links:
Genes affected
INF2 (HGNC:23791): (inverted formin 2) This gene represents a member of the formin family of proteins. It is considered a diaphanous formin due to the presence of a diaphanous inhibitory domain located at the N-terminus of the encoded protein. Studies of a similar mouse protein indicate that the protein encoded by this locus may function in polymerization and depolymerization of actin filaments. Mutations at this locus have been associated with focal segmental glomerulosclerosis 5.[provided by RefSeq, Aug 2010]
INF2 Gene-Disease associations (from GenCC):
  • Charcot-Marie-Tooth disease dominant intermediate E
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), ClinGen
  • focal segmental glomerulosclerosis 5
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • familial idiopathic steroid-resistant nephrotic syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_022489.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.72).
BP6
Variant 14-104714231-C-T is Benign according to our data. Variant chr14-104714231-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 261614.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.766 with no splicing effect.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.00471 (718/152290) while in subpopulation AMR AF = 0.00843 (129/15302). AF 95% confidence interval is 0.00725. There are 3 homozygotes in GnomAd4. There are 318 alleles in the male GnomAd4 subpopulation. Median coverage is 34. This position passed quality control check.
BS2
High AC in GnomAd4 at 718 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_022489.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
INF2
NM_022489.4
MANE Select
c.3069C>Tp.Pro1023Pro
synonymous
Exon 21 of 23NP_071934.3Q27J81-1
INF2
NM_001426862.1
c.3069C>Tp.Pro1023Pro
synonymous
Exon 21 of 23NP_001413791.1
INF2
NM_001426863.1
c.3069C>Tp.Pro1023Pro
synonymous
Exon 21 of 23NP_001413792.1Q27J81-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
INF2
ENST00000392634.9
TSL:5 MANE Select
c.3069C>Tp.Pro1023Pro
synonymous
Exon 21 of 23ENSP00000376410.4Q27J81-1
INF2
ENST00000617571.5
TSL:1
n.3065C>T
non_coding_transcript_exon
Exon 20 of 22ENSP00000483829.2A0A087X118
INF2
ENST00000675207.1
c.3165C>Tp.Pro1055Pro
synonymous
Exon 21 of 23ENSP00000502644.1A0A6Q8PHA2

Frequencies

GnomAD3 genomes
AF:
0.00472
AC:
718
AN:
152172
Hom.:
3
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.00164
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00844
Gnomad ASJ
AF:
0.00288
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.00228
Gnomad FIN
AF:
0.00226
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.00675
Gnomad OTH
AF:
0.00670
GnomAD2 exomes
AF:
0.00505
AC:
940
AN:
186012
AF XY:
0.00523
show subpopulations
Gnomad AFR exome
AF:
0.00109
Gnomad AMR exome
AF:
0.00592
Gnomad ASJ exome
AF:
0.00222
Gnomad EAS exome
AF:
0.0000673
Gnomad FIN exome
AF:
0.00322
Gnomad NFE exome
AF:
0.00699
Gnomad OTH exome
AF:
0.00690
GnomAD4 exome
AF:
0.00620
AC:
8754
AN:
1411208
Hom.:
50
Cov.:
69
AF XY:
0.00607
AC XY:
4233
AN XY:
697364
show subpopulations
African (AFR)
AF:
0.000833
AC:
27
AN:
32406
American (AMR)
AF:
0.00588
AC:
238
AN:
40506
Ashkenazi Jewish (ASJ)
AF:
0.00231
AC:
55
AN:
23804
East Asian (EAS)
AF:
0.000133
AC:
5
AN:
37574
South Asian (SAS)
AF:
0.00399
AC:
312
AN:
78268
European-Finnish (FIN)
AF:
0.00365
AC:
168
AN:
45978
Middle Eastern (MID)
AF:
0.0114
AC:
64
AN:
5624
European-Non Finnish (NFE)
AF:
0.00689
AC:
7500
AN:
1088620
Other (OTH)
AF:
0.00659
AC:
385
AN:
58428
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
483
966
1450
1933
2416
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
286
572
858
1144
1430
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00471
AC:
718
AN:
152290
Hom.:
3
Cov.:
34
AF XY:
0.00427
AC XY:
318
AN XY:
74450
show subpopulations
African (AFR)
AF:
0.00164
AC:
68
AN:
41562
American (AMR)
AF:
0.00843
AC:
129
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.00288
AC:
10
AN:
3470
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5184
South Asian (SAS)
AF:
0.00228
AC:
11
AN:
4830
European-Finnish (FIN)
AF:
0.00226
AC:
24
AN:
10616
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.00675
AC:
459
AN:
68010
Other (OTH)
AF:
0.00664
AC:
14
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
42
84
126
168
210
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00551
Hom.:
1
Bravo
AF:
0.00486
Asia WGS
AF:
0.00346
AC:
12
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
4
not provided (4)
-
-
2
not specified (2)
-
-
1
Focal segmental glomerulosclerosis (1)
-
-
1
Focal segmental glomerulosclerosis 5 (1)
-
-
1
Focal segmental glomerulosclerosis 5;C4302667:Charcot-Marie-Tooth disease dominant intermediate E (1)
-
-
1
Inborn genetic diseases (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.72
CADD
Benign
2.2
DANN
Benign
0.56
PhyloP100
-0.77
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs75382114;
hg19: chr14-105180568;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.